QPS

NEWS DESK

QPS Expands Offerings With Robust Pharmacology Disease Models, Including MASH, Ulcerative Colitis, Wound Healing, and Psoriasis

PR News Desk 24/04/2025

QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion of its pharmacology disease models portfolio to include highly relevant and sophisticated models for metabolic

NEWS DESK

QPS Launches New Leukopak and Cell Therapy Products Facility

PR News Desk 14/11/2024

QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy business unit. The unit’s first achievement is the opening of a new Leukopak collection and blood product processing center. This facility is designed to meet the exponentially growing demand for blood products to support cell and gene therapy […]

NEWS DESK

QPS Announces New Laboratory Services for Clinical Trials and Cell Therapy Development

News Desk 27/06/2024

QPS, a leading global contract research organization (CRO), is pleased to announce new laboratory services capabilities. The central laboratory, leukopak cell therapy facility, and enhanced PBMC capabilities will complement existing bioanalysis, translational medicine and peripheral blood mononuclear cell (PMBC) laboratories and extend the current QPS full-service global

NEWS DESK

QPS Announces New Global Clinical Research Operations Leadership

News Desk 21/06/2024

QPS, a leading global contract research organization (CRO), is pleased to announce new clinical research operations leadership. This new clinical leadership will further align the existing global medical affairs, regulatory affairs, data services, and clinical operations units with the existing successful QPS Phase I clinics. The enhanced global capabilities will help QPS

NEWS DESK

QPS Expands Clinic in Miami, Florida to Accommodate Increasing Demand for Obesity Trials

News Desk 22/05/2024

QPS, a leading global contract research organization (CRO), continues to expand and align its full-service preclinical, bioanalysis, and clinical capabilities with the evolution of demand for clinical trials. Today, QPS announced the expansion of its Miami, Florida Phase I clinical trial capabilities to support the growing needs of sponsors. QPS announces the grand opening